Skip to main content
Livermore
Livermore
ZHEN

Baker Bros. Advisors LP

SEC CIK
0001263508
Latest filing
Aug 14, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q2 2026)
42,912,904
Value
$1.09B
% of portfolio
5.4%
Quarters held
22
Since Q1 2021
Holdings of ACAD by Baker Bros. Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202642,912,904$1.09B5.4%+16,2140.0%AddedHolders
Q1 202642,896,690$954.9M5.5%00.0%UnchangedHolders
Q4 202542,896,690$1.15B6.7%00.0%UnchangedHolders
Q3 202542,896,690$915.4M6.6%00.0%UnchangedHolders
Q2 202542,896,690$925.3M9.0%+18,7740.0%AddedHolders
Q1 202542,877,916$712.2M7.9%00.0%UnchangedHolders
Q4 202442,877,916$786.8M8.4%00.0%UnchangedHolders
Q3 202442,877,916$659.5M6.8%00.0%UnchangedHolders
Q2 202442,877,916$696.8M8.9%+13,3040.0%AddedHolders
Q1 202442,864,612$792.6M9.9%00.0%UnchangedHolders
Q4 202342,864,612$1.34B15.3%00.0%UnchangedHolders
Q3 202342,864,612$893.3M5.1%00.0%UnchangedHolders
Q2 202342,864,612$1.03B5.9%+926,126+2.2%AddedHolders
Q1 202341,938,486$789.3M4.3%+15,0000.0%AddedHolders
Q4 202241,923,486$667.4M4.0%00.0%UnchangedHolders
Q3 202241,923,486$685.9M4.5%00.0%UnchangedHolders
Q2 202241,923,486$590.7M3.4%+12,7820.0%AddedHolders
Q1 202241,910,704$1.02B5.8%00.0%UnchangedHolders
Q4 202141,910,704$978.2M4.8%00.0%UnchangedHolders
Q3 202141,910,704$696.1M3.1%00.0%UnchangedHolders
Q2 202141,910,704$1.02B4.5%00.0%UnchangedHolders
Q1 202141,910,704$1.08B4.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.